Movone (Dexibuprofen)

Dexibuprofen, the active ingredient in Movone, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use and marketed in the European Union. It is employed to relieve pain, reduce inflammation, and lower fever in adult patients.

GNH USA supplies Movone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for healthcare providers seeking quality NSAID products and supporting global health initiatives.

Dexibuprofen acts as an NSAID that alleviates symptoms associated with inflammatory pathways.

- Pain: Provides analgesic relief by decreasing prostaglandin‑mediated nociception. - Inflammation: Reduces swelling and tissue inflammation in musculoskeletal conditions. - Fever: Lowers elevated body temperature by inhibiting pyrogenic prostaglandin synthesis.

Dexibuprofen may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal discomfort: dyspepsia, abdominal pain, or nausea. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Skin rash or mild itching.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or acute kidney injury. - Hepatic enzyme elevation or liver injury. - Severe hypersensitivity reactions, including Stevens‑Johnson syndrome. - Cardiovascular events such as myocardial infarction or stroke.

When using Dexibuprofen, several precautions should be observed to minimise risk.

- Assess renal function: evaluate kidney status before initiating therapy in patients with renal disease. - Monitor hepatic health: avoid use in patients with active liver disease or elevated transaminases. - Use lowest effective dose: limit duration to the shortest period necessary to control symptoms. - Caution in cardiovascular risk: consider alternative therapy for patients with history of heart failure or thrombotic events. - Store at room temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Dexibuprofen can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Corticosteroids: heightened risk of ulceration. - ACE inhibitors or ARBs: possible reduction in renal function. - Lithium: elevated lithium serum levels.

Moderate Interactions (Monitor Closely): - Diuretics: may impair renal clearance. - Methotrexate: reduced elimination leading to toxicity. - SSRIs or SNRIs: potential for increased bleeding. - Oral hypoglycemics: possible alteration of blood glucose control.